Picture of Consun Pharmaceutical logo

1681 — Consun Pharmaceutical News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareBalancedMid CapSuper Stock

Brief: Consun Pharmaceutical Group Updates On Progress In Application For New Medicine Registration

March 15 (Reuters) - Consun Pharmaceutical Group Ltd
 1681.HK :
    * UNITS ‍GRANTED "CLINICAL TRIAL APPROVAL" BY CHINA FDA FOR
"ASTRAGALI POWDER PELLET", A PIPELINE MEDICINE​

Source text for Eikon:  ID:nHKS950M9F 
Further company coverage:  1681.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Consun Pharmaceutical

See all news